We use cookies for a better user experience. Read our Privacy Policy
I Agree
Allergy Immunotherapy Market
Allergy Immunotherapy Market – Snapshot
The global allergy immunotherapy market is expanding at a considerable pace due to high prevalence and rise in incidences of allergies across the globe. The global allergy immunotherapy market was valued at US$ 1.37 Bn in 2016 and is projected to expand at CAGR of 10.7% from 2017 to 2025 to exceed the US$ 3.33 Bn by 2025. Expansion of the global allergy immunotherapy market is attributed to the rise in awareness regarding allergy treatment, rapidly growing allergic population, and launch of new products.
Allergy immunotherapy, also referred to as desensitization or hypo-sensitization, is a medical treatment targeted for different types of allergies. There is an increase in prevalence of allergy and pharmacotherapy alone is insufficient to control the disease. The allergy immunotherapeutic treatment helps increase immunological tolerance and alters the disease course. The desensitization therapy provides long-term effect, which extends past the conclusion of treatment. This therapy helps improve the quality of life of patients with allergies.
As per the World Allergy Organization (WAO), there has been a significant rise in prevalence of allergic diseases across the world in last 50 years. According to Summary Health Statistics for U.S. Adults: 2010 National Health Interview Survey, over 8% and 13% of adult people in the U.S. have hay fever and sinusitis, respectively. According to WAO, around 30% of the global population suffers from allergic rhinitis alone. Thereby, high prevalence and incidence rate of allergy across the globe are driving the global allergy immunotherapy market. Additionally, increase in awareness about allergy treatment and high clinical R&D budget by governments and non-profit organizations are projected to fuel the allergy immunotherapy market during the forecast period. Promising product pipeline creates opportunities for business development during the forecast period. Across the world, there are around 10 different drugs in phase-3 of the clinical pipeline studies for treating different allergy symptoms.
The subcutaneous immunotherapy (SCIT), is extensively used and effective form of allergy immunotherapy. The SCIT treatment alters the immune system, thereby preventing the development of new allergies and asthma. Allergy tablets are a type of SLIT that treat certain allergies. These allergy tablets decrease the symptoms by helping the body build resistance to allergen effects. However, tablets can only treat a single type of allergen and do not avoid new allergies development and asthma. In 2014, the US Food and Drug administration (FDA) approved SLIT tablets to treat ragweed and grass pollen allergies.
The global allergy immunotherapy market is divided into four segments based on treatment type, allergy type, distribution channel, and geography. In terms of treatment type, the global allergy immunotherapy market is segmented into SCIT and SLIT. SCIT dominated the global allergy immunotherapy market in 2016, account for more than 65% share of the market. The segment is projected to expand at a moderate pace and gain market share during the forecast period.
In terms of allergy type, the global allergy immunotherapy market is classified into allergic rhinitis, asthma, food allergy, venom allergy, and others. The allergic rhinitis segment accounted for a leading share of the global market. The segment is projected to continue its dominance during the forecast period. The asthma segment accounted for a significant share of the market due to effectiveness of SCIT and SLIT in the treatment of allergic asthma. The other segment includes allergies such as latex allergy, pollen allergy, and mold allergy. Distribution channels include hospital pharmacies, retail pharmacies & drug stories, and online pharmacies. The hospital pharmacies segment dominated the global allergy immunotherapy market in 2016 and is likely to gain share by the end of 2025.
Geographically, the allergy immunotherapy market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe accounted for the largest share of the global allergy immunotherapy market in 2016, followed by North America. Europe accounts for a large share of the market due to high awareness, increase in funding for research and grants, favorable medical reimbursement policies, rise in allergic population, and promising clinical pipeline products. The region is a highly attractive market and is anticipated to expand at a significant CAGR during the forecast period. The allergy immunotherapy market in Asia Pacific is anticipated to expand at a moderate growth rate. Majority of the market share of allergy immunotherapy is captured by Japan and China in Asia-Pacific region, owing to the presence of huge allergic population in these countries.
The global allergy immunotherapy market is consolidated with some companies accounting for majority share. Leading players operating in the global allergy immunotherapy market include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Merck KGaA (Allergopharma), and HAL Allergy Group. Manufacturers are adopting new SLIT therapies commercialization in the international market to tap the unmet needs of allergy immunotherapy. Other prominent players operating in the global market include Biomay AG, Anergis, Aimmune Therapeutics, Circassia and DBV Technologies.
The global allergy immunotherapy market has been segmented as follows:
|
Treatment Type |
|
|
Allergy Type |
|
|
Distribution Channel |
|
|
Region |
|
Chapter 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary: Global Allergy Immunotherapy Market
Chapter 4 Market Overview
4.1. Introduction
4.2. Key Industry Developments
Chapter 5 Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
5.5. Global Allergy Immunotherapy Market Outlook
Chapter 6 Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment Type
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
6.3.1. Subcutaneous Immunotherapy (SCIT)
6.3.2. Sublingual Immunotherapy(SLIT)
6.4. Market Attractiveness Analysis, by Treatment Type
Chapter 7 Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type
7.1. Key Findings
7.2. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
7.2.1. Allergic Rhinitis
7.2.2. Asthma
7.2.3. Food Allergy
7.2.4. Venom Allergy
7.2.5. Others
7.3. Market Attractiveness Analysis, by Allergy Type
7.4. Key Trends
Chapter 8 Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
8.3.1. Hospital Pharmacy
8.3.2. Retail Pharmacy and Drug Stores
8.3.3. Online Pharmacy
8.4. Market Attractiveness Analysis, by Distribution Channel
Chapter 9 Global Allergy Immunotherapy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Market Scenario
9.3. Market Value (US$ Mn) Forecast, by Region, 2017–2025
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis, by Region
Chapter 10 North America Allergy Immunotherapy Market Analysis and Forecast
10.1. Key Findings
10.2. Market Size (US$ Mn) Forecast, by Country, 2017–2025
10.2.1. U.S.
10.2.2. Canada
10.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
10.3.1. SCIT
10.3.2. SLIT
10.4. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
10.4.1. Allergic Rhinitis
10.4.2. Asthma
10.4.3. Food Allergy
10.4.4. Venom Allergy
10.4.5. Other
10.5. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
10.5.1. Hospital Pharmacy
10.5.2. Retail Pharmacy and Drug Stores
10.5.3. Online Pharmacy
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Treatment Type
10.6.3. By Allergy Type
10.6.4. By Distribution Channel
Chapter 11 Europe Allergy Immunotherapy Market Analysis and Forecast
11.1. Key Findings
11.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
11.3.1. SCIT
11.3.2. SLIT
11.4. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
11.4.1. Allergic Rhinitis
11.4.2. Asthma
11.4.3. Food Allergy
11.4.4. Venom Allergy
11.4.5. Others
11.5. Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
11.5.1. Hospital Pharmacy
11.5.2. Retail Pharmacy and Drug Stores
11.5.3. Online Pharmacy
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Treatment Type
11.6.3. By Allergy Type
11.6.4. By Distribution Channel
Chapter 12 Asia Pacific Allergy Immunotherapy Market Analysis and Forecast
12.1. Key Findings / Developments
12.2. Market Overview
12.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
12.4.1. SCIT
12.4.2. SLIT
12.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
12.5.1. Allergic Rhinitis
12.5.2. Asthma
12.5.3. Food Allergy
12.5.4. Venom Allergy
12.5.5. Others
12.6. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
12.6.1. Hospital Pharmacy
12.6.2. Retail Pharmacy and Drug Stores
12.6.3. Online Pharmacy
12.7. Market Attractiveness Analysis
12.7.1. By Country
12.7.2. By Treatment Type
12.7.3. By Allergy Type
12.7.4. By Distribution Channel
Chapter 13 Latin America Allergy Immunotherapy Market Analysis and Forecast
13.1. Key Findings / Developments
13.2. Market Overview
13.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
13.4.1. SCIT
13.4.2. SLIT
13.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017-2025
13.5.1. Allergic Rhinitis
13.5.2. Asthma
13.5.3. Food Allergy
13.5.4. Venom Allergy
13.5.5. Others
13.6. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
13.6.1. Hospital Pharmacy
13.6.2. Retail Pharmacy and Drug Stores
13.6.3. Online Pharmacy
13.7. Market Attractiveness Analysis
13.7.1. By Country/Sub-region
13.7.2. By Treatment Type
13.7.3. By Allergy Type
13.7.4. By Distribution Channel
Chapter 14 Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast
14.1. Key Findings / Developments
14.2. Market Overview
14.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Israel
14.3.4. Rest of Middle East & Africa
14.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
14.4.1. SCIT
14.4.2. SLIT
14.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
14.5.1. Allergic Rhinitis
14.5.2. Asthma
14.5.3. Food Allergy
14.5.4. Venom Allergy
14.5.5. Others
14.6. Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
14.6.1. Hospital Pharmacy
14.6.2. Retail Pharmacy and Drug Stores
14.6.3. Online Pharmacy
14.7. Market Attractiveness Analysis
14.7.1. By Country/Sub-region
14.7.2. By Treatment Type
14.7.3. By Allergy Type
14.7.4. By Distribution Channel
Chapter 15 Pipeline Analysis
15.1.1. Allergy Immunotherapy Pipeline Analysis (2017)
Chapter 16 Allergy Immunotherapy – Regulatory Overview
16.1.1. Regulatory Status for European Union
16.1.2. Regulatory Status for U.S.
Chapter 17 Competition Landscape
17.1. Global Allergy Immunotherapy Market Share, by Company, 2017
17.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
17.2.1. ALK-Abello A/S
17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.1.2. Product Portfolio
17.2.1.3. SWOT Analysis
17.2.1.4. Strategic Overview
17.2.2. Allergy Therapeutics
17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.2.2. Product Portfolio
17.2.2.3. SWOT Analysis
17.2.2.4. Strategic Overview
17.2.3. Stallergenes Greer
17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.3.2. Product Portfolio
17.2.3.3. SWOT Analysis
17.2.3.4. Financial Overview
17.2.3.5. Strategic Overview
17.2.4. HAL Allergy Group
17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.4.2. Product Portfolio
17.2.4.3. SWOT Analysis
17.2.4.4. Financial Overview
17.2.4.5. Strategic Overview
17.2.5. DBV Technologies
17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.5.2. Product Portfolio
17.2.5.3. SWOT Analysis
17.2.5.4. Financial Overview
17.2.5.5. Strategic Overview
17.2.6. Merck KGaA
17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.6.2. Product Portfolio
17.2.6.3. SWOT Analysis
17.2.6.4. Financial Overview
17.2.6.5. Strategic Overview
17.2.7. Aimmune Therapeutics
17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.7.2. Product Portfolio
17.2.7.3. SWOT Analysis
17.2.7.4. Financial Overview
17.2.7.5. Strategic Overview
17.2.8. Circassia
17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.8.2. Product Portfolio
17.2.8.3. SWOT Analysis
17.2.8.4. Financial Overview
17.2.8.5. Strategic Overview
17.2.9. Anergis
17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.9.2. Product Portfolio
17.2.9.3. SWOT Analysis
17.2.9.4. Financial Overview
17.2.9.5. Strategic Overview
17.2.10. Biomay AG
17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.10.2. Product Portfolio
17.2.10.3. SWOT Analysis
17.2.10.4. Financial Overview
17.2.10.5. Strategic Overview
List of Tables
Table 01: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 02: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 03: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 04: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 06: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel , 2015–2025
Table 07: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 08: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 10: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 11: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 12: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 13: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 14: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 15: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Types, 2015–2025
Table 18: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 19: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 20: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 21: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 22: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 23: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 24: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
List of Figures
Figure 01: Market Snapshot
Figure 02: Market Value Share By Treatment Type (2017) Value (US$ Mn)
Figure 03: Market Value Share By Allergy Type (2017) Value (US$ Mn)
Figure 04: Market Value Share By Distribution Channel (2017) Value (US$ Mn)
Figure 05: Global Allergy Immunotherapy Market Value Share Analysis, by Type, 2016 and 2025
Figure 06: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by SCIT, 2015–2025
Figure 07: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by SLIT, 2015–2025
Figure 8: Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 09: Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 10: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2015–2025
Figure 11: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2015–2025
Figure 12: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies and Drug Store, 2015–2025
Figure 13: Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 14: Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 15: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allergic Rhinitis, 2015–2025
Figure 16: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Asthma, 2015–2025
Figure 17: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Food Allergy, 2015–2025
Figure 18: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Venom Allergy, 2015–2025
Figure 19: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2027
Figure 20: Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type , 2017–2025
Figure 21: Global Allergy Immunotherapy Market Value Share Analysis, by Region, 2016 and 2025
Figure 22: Global Allergy Immunotherapy Market Attractiveness Analysis, by Region, 2017–2025
Figure 23: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 24: North America Allergy Immunotherapy Y-o-Y Growth (%) Projection, 2016–2025
Figure 25: North America Allergy Immunotherapy Market Attractiveness, by Country, 2017–2025
Figure 26: North America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 27: North America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 28: North America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 29: North America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 30: North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 31: North America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 32: North America Allergy Immunotherapy Market Value Share Analysis, by Country, 2016 and 2025
Figure 33: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 34: Europe Allergy Immunotherapy Market Y-o-Y Growth Projections, 2016–2025
Figure 35: Europe Allergy Immunotherapy Market Attractiveness, by Country, 2016
Figure 36: Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 37: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 38: Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 39: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 40: Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 41: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 42: Europe Allergy Immunotherapy Market, by Country, 2016 and 2025
Figure 43: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 44: Asia Pacific Allergy Immunotherapy Market Y-o-Y Growth Projections, 2016–2025
Figure 45: Asia Pacific Allergy Immunotherapy Market Attractiveness, by Country, 2016
Figure 46: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 47: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 48: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 49: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 50: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 51: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 52: Asia Pacific Surgical Drapes Market, by Country, 2016 and 2025
Figure 53: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 54: Latin America Allergy Immunotherapy Y-o-Y Growth Projections, 2016–2025
Figure 55: Latin America Allergy Immunotherapy Market Attractiveness, by Country, 2016
Figure 56: Latin America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 57: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 58: Latin America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 59: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 60: Latin America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 61: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 62: Latin America Allergy Immunotherapy Market, by Country, 2016 and 2025
Figure 63: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 64: Middle East & Africa Allergy Immunotherapy Y-o-Y Growth (%) Projection, 2016–2025
Figure 65: Middle East & Africa Allergy Immunotherapy Market Attractiveness, by Country, 2017-2025
Figure 66: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 67: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 68: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 69: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 70: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 71: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 72: Middle East & Africa Allergy Immunotherapy Market, by Country, 2016 and 2025
Figure 73: Global Allergy Therapeutics Market Share Analysis, by Company (2017)
Figure 74: ALK-Abello A/S Global Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 75: ALK-Abello A/S Global Operating Profit (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 76: ALK-Abello A/S Breakdown of Net Sales, by Region, 2017
Figure 77: ALK-Abello A/S Breakdown of Net Sales, by Business Segment, 2017
Figure 78: Allergy Therapeutics Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 79: Allergy Therapeutics Breakdown of Net Sales, by Region, 2017
Figure 80: Allergy Therapeutics Breakdown of Net Sales, by Business Segment, 2017
Figure 81: Stallergenes Greer Breakdown of Net Sales, by Business Segment, 2017
Figure 82: Stallergenes Greer R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 83: Stallergenes Greer Breakdown of Net Sales, by Region, 2017
Figure 84: Stallergenes Greer Breakdown of Net Sales, by Business Segment, 2017
Figure 85: Merck KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 86: Merck KGaA R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 87: Merck KGaA Breakdown of Net Sales, by Region, 2017
Figure 88: Merck KGaA Breakdown of Net Sales, by Business Segment, 2017
Figure 89: Circassia Global Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 90: Circassia Global Research and Development Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes